Lakshman Gollapalli, MD
Interventional Pain Medicine · Chandler, AZNPI 1578850756
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,420 of the $15,742 with a category attached, or 78.9%. It is spread thinly across 35 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $3,337 and has fallen 63.3% since, to $1,225 in 2025.
Across 362 payments — averaging $43.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Vertos Medical, Inc.$2K
- Medtronic$2K
- Boston Scientific$2K
- Nevro Corp.$2K
- Spinal Simplicity, LLC$1K
- plus $3K from 29 others
What the payments were for
- Travel & lodging$3,31021%
- Food & beverage$12,42079%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 103 | $3,647 |
| Vertos Medical, Inc. | 25 | $2,352 |
| Medtronic(2 entities) | 35 | $1,739 |
| Boston Scientific | 59 | $1,644 |
| Nevro Corp. | 21 | $1,616 |
| Spinal Simplicity, LLC | 12 | $1,428 |
| Curonix LLC | 4 | $630 |
| Saluda Medical Americas, Inc. | 24 | $473 |
| Stimwave Technologies Incorporated | 4 | $386 |
| Collegium Pharmaceutical, Inc. | 15 | $196 |
| Stryker | 1 | $166 |
| Life Spine, Inc. | 1 | $136 |
| Zavation Medical Products, LLC | 1 | $131 |
| AbbVie(2 entities) | 6 | $131 |
| Spineology Inc. | 1 | $127 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $108 |
| Biodelivery Sciences International, Inc. | 7 | $95 |
| Teva Pharmaceuticals USA, Inc. | 6 | $92 |
| Nalu Medical, Inc. | 3 | $75 |
| Painteq LLC | 2 | $73 |
| Johnson & Johnson | 4 | $65 |
| Foundation Fusion Solutions, LLC | 1 | $65 |
| Pacira Therapeutics, Inc. | 3 | $55 |
| Novartis | 3 | $42 |
| Tonix Medicines, Inc. | 1 | $33 |
| Radius Health, Inc. | 1 | $32 |
| GRT US Holding, Inc. | 2 | $31 |
| Redhill Biopharma Inc. | 2 | $30 |
| Vertex | 1 | $25 |
| Almatica Pharma LLC | 2 | $24 |
| Fidia Pharma USA Inc. | 1 | $23 |
| ZOLL Respicardia, Inc. | 1 | $22 |
| Si-bone, Inc. | 1 | $20 |
| Biotronik NRO, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$1,814
- HA MINUTEMAN G3-R$1,331
- Senza Spinal Cord Stimulation System$1,150
- Proclaim Family of SCS IPGs$976
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$583
- Proclaim IPG$413
- PROCLAIM$396
- INTELLIS ADAPTIVESTIM$394
- OCTRODE$302
- INTELLIS$298
- SYNCHROMEDII$245
- Axium Sheath Braided DRG$169
- IVS - VERTEBRAL AUGMENTATION PRODUCTS$166
- ARTISAN$142
- AILERON EXPANDABLE POSTERIOR FUSION SYSTEM$136
- SIBI System$131
- Rampart Duo Interbody Fusion System$127
- GENERAL PAIN MANAGEMENT$125
- Penta SCS Leads$116
- SUPERION$110
How this compares
$15,742 in reported general payments places this provider in the 70th percentile of 64 interventional pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 21 | $15,011 |
| BelbucaBuprenorphine Hcl | 14 | $13,769 |
| Oxycodone Hcl | 488 | $10,863 |
| OxycontinOxycodone Hcl | 13 | $9,135 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 285 | $8,486 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 182 | $6,669 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 30 | $4,558 |
| Fentanyl | 22 | $3,082 |
| Morphine Sulfate ErMorphine Sulfate | 95 | $2,291 |
| Pregabalin | 52 | $1,540 |
| Gabapentin | 91 | $1,158 |
| Hydromorphone Hcl | 53 | $1,101 |
| Naloxone Hcl | 19 | $1,032 |
| Tramadol Hcl | 95 | $814 |
| Lidocaine | 13 | $767 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $196 | $28,78035 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 64 interventional pain medicine providers in Arizona.
Other interventional pain medicine in Chandler
- David RayChandler$14K
- Karl Hurst-WickerChandler$9K
- Sheba ShahChandler$3K
- Paul LynchScottsdale$283K
- Jack DiepLake Havasu City$233K
- Matthew RansonMesa$86K
- Steven SiwekPhoenix$57K
- Ajay YedduGilbert$52K
- Ramoun JonesPhoenix$51K
- Lisa StearnsPhoenix$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.